|
|
|
|
| LEADER |
00000cam a2200000 c 4500 |
| 001 |
1461247934 |
| 003 |
DE-627 |
| 005 |
20240705203611.0 |
| 007 |
tu |
| 008 |
130718s2013 xx ||||| m 00| ||eng c |
| 035 |
|
|
|a (DE-627)1461247934
|
| 035 |
|
|
|a (DE-576)39124793X
|
| 035 |
|
|
|a (DE-599)BSZ39124793X
|
| 035 |
|
|
|a (OCoLC)855555866
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 084 |
|
|
|a 30
|2 sdnb
|
| 100 |
1 |
|
|a Kannengießer, Stefanie
|0 (DE-588)1037175611
|0 (DE-627)75238600X
|0 (DE-576)391178474
|4 aut
|
| 245 |
1 |
0 |
|a Optimization of the synthesis of Ac-225-labelled DOTA-radioimmunoconjugates for targeted alpha therapy, based on investigations on the complexation of trivalent actinides by DOTA
|c vorgelegt von Stefanie Kannengießer
|
| 247 |
1 |
0 |
|a Optimierung der Synthese von Ac-225-markierten DOTA-Radioimmunkonjugaten für die zielgerichtete Alpha-Therapie, basierend auf Untersuchungen zur Komplexierung dreiwertiger Actiniden durch DOTA
|f Übers. des Hauptsacht.
|
| 264 |
|
1 |
|c 2013
|
| 300 |
|
|
|a 229 S.
|b Ill., graph. Darst.
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Zsfassung in dt. Sprache
|
| 502 |
|
|
|a Heidelberg, Univ., Diss., 2013
|
| 583 |
1 |
|
|a Archivierung/Langzeitarchivierung gewährleistet
|f DISS
|x XA-DE-BW
|2 pdager
|5 DE-16
|
| 655 |
|
7 |
|a Hochschulschrift
|0 (DE-588)4113937-9
|0 (DE-627)105825778
|0 (DE-576)209480580
|2 gnd-content
|
| 751 |
|
|
|a Heidelberg
|0 (DE-588)4023996-2
|0 (DE-627)106300814
|0 (DE-576)208952578
|4 uvp
|
| 776 |
0 |
8 |
|i Erscheint auch als
|n Online-Ausgabe
|a Kannengießer, Stefanie
|t Optimization of the synthesis of Ac-225-labelled DOTA-radioimmunoconjugates for targeted alpha therapy, based on investigations on the complexation of trivalent actinides by DOTA
|d 2013
|h Online-Ressource
|w (DE-627)1652928723
|w (DE-576)391178520
|
| 856 |
4 |
2 |
|u http://d-nb.info/103855229X/04
|m B:DE-101
|q application/pdf
|3 Inhaltsverzeichnis
|
| 951 |
|
|
|a BO
|
| 992 |
|
|
|a 20210531
|
| 993 |
|
|
|a Thesis
|
| 998 |
|
|
|g 1037175611
|a Kannengießer, Stefanie
|m 1037175611:Kannengießer, Stefanie
|d 120000
|e 120000PK1037175611
|k 0/120000/
|p 1
|x j
|y j
|
| 999 |
|
|
|a KXP-PPN1461247934
|e 3932677013
|
| BIB |
|
|
|a Y
|
| JSO |
|
|
|a {"physDesc":[{"extent":"229 S.","noteIll":"Ill., graph. Darst."}],"id":{"eki":["1461247934"]},"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"2013"}],"name":{"displayForm":["vorgelegt von Stefanie Kannengießer"]},"titleAlt":[{"title":"Optimierung der Synthese von Ac-225-markierten DOTA-Radioimmunkonjugaten für die zielgerichtete Alpha-Therapie, basierend auf Untersuchungen zur Komplexierung dreiwertiger Actiniden durch DOTA"}],"recId":"1461247934","language":["eng"],"type":{"bibl":"thesis"},"note":["Zsfassung in dt. Sprache"],"title":[{"title_sort":"Optimization of the synthesis of Ac-225-labelled DOTA-radioimmunoconjugates for targeted alpha therapy, based on investigations on the complexation of trivalent actinides by DOTA","title":"Optimization of the synthesis of Ac-225-labelled DOTA-radioimmunoconjugates for targeted alpha therapy, based on investigations on the complexation of trivalent actinides by DOTA"}],"person":[{"given":"Stefanie","family":"Kannengießer","role":"aut","display":"Kannengießer, Stefanie"}],"noteThesis":["Heidelberg, Univ., Diss., 2013"]}
|
| SRT |
|
|
|a KANNENGIESOPTIMIZATI2013
|
